Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: Incidence and management

Transplantation Proceedings

Volumn 36, Issue 3, 2004, Pages 778-779

  Veiga Barreiro, A ^a,c   Crespo Leiro, M ^b   Domenech Garcia N ^c   Paniagua, M J ^b   Vazquez Martul E ^a   Gonzalez Cuesta M ^a   Ramirez C ^b   Juffe Stein A ^b   Castro Beiras, A ^b,d  

^a Department of Pathology ^*  (Spain)

^b Area of the Heart   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d Healthy Science Institute   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART DISEASE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BIOPSY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 2042511678     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.03.033     Document Type: Conference Paper

References (8)

1. Grauhan O., Knosalla C., Ewert R., et al. Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. J Heart Lung Transplant. 20:2001;316
2. Michaels P., Espejo M., Kobashigawa J., et al. Humoral rejection in cardiac transplantation risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 22:2003;58
3. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation pathologic observations and clinical implications. J Heart Transplant. 8:1989;430
4. Hammond E.H., Yowell R.L., Price G.D., et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant. 11:1992;S111
5. Bonnaud E., Lewis N., Masek M., et al. Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant. 14:1995;163
6. Behr T.M., Feucht H.E., Richter K., et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant. 18:1999;904
7. Fredrich R., Toyoda M., Czer L., et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation. 67:1999;385
8. Rodriguez E. The pathology of heart transplant biopsy specimens revisiting the 1990 ISHLT working formulation. J Heart Lung Transplant. 22:2003;3